Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a

NCT02218736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

163

Enrollment

OTHER

Sponsor class

Conditions

ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)

Interventions

DRUG: CERC-501
DRUG: placebo

Sponsor

Duke University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]